Sarcio
Apple Valley, US · Founded 2020 · Minnesota corporation · 1 known investors
Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.
Founders & leadership
Sarcio was founded in 2020 by Timothy D. O'Brien.
TD
Timothy D. O'BrienFounder & Chief Scientific Officer, Director
TO
Timothy O'BrienChief Scientific Officer & Director
AV
Amanda VegoeFounder & Chief Operations Officer
BL
Beth LindborgFounder & Chief Executive Officer, Director
MT
Marc TompkinsChief Medical Officer
MW
Michael WilliamsChief Business Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 2 rounds · 2021
▶$785.3KraisedAug 2023 · 23 investors · BiotechnologyRule 506(b)
▶$785.3KraisedAug 2023 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Beth LindborgExecutive Officer, Director
- Michael WilliamsDirector
- Amanda VegoeExecutive Officer
- Marc TompkinsExecutive Officer
- Timothy O'BrienExecutive Officer, Director
- Offering amount
- $850K
- Amount sold
- $785.3K
- Proceeds to insiders
- $120K
- First sale
- Mar 2021
- Incorporated
- Corporation, Minnesota, 2020
- Federal exemptions
- 06b, 4a5
▶$607.5KraisedJul 2023 · 13 investors · BiotechnologyRule 506(b)
▶$607.5KraisedJul 2023 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy O'BrienExecutive Officer, Director
- Amanda VegoeExecutive Officer
- Beth LindborgExecutive Officer, Director
- Marc TompkinsExecutive Officer
- Michael WilliamsDirector
- Offering amount
- $750K
- Amount sold
- $607.5K
- First sale
- Dec 2021
- Incorporated
- Corporation, Minnesota, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Sarcio do?
- Sarcio Inc. is a University of Minnesota Stem Cell Institute spin-out developing regenerative, disease-modifying therapeutics by isolating exosomes from iPSC-derived cartilage tissue to treat osteoarthritis and restore joint function. The company aims to delay or eliminate the need for joint-replacement surgery.
- Who founded Sarcio?
- Sarcio was founded by Timothy D. O'Brien in 2020.
- Who are Sarcio's investors?
- Sarcio's investors include GROOVE CAPITAL.
- How much funding has Sarcio raised?
- Sarcio has disclosed $1.4M raised across 2 rounds.
- Where is Sarcio headquartered?
- Sarcio is headquartered in Apple Valley, US.